Image Description (Chemical Structure)
Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 13668-509
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 13668-509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Description (Container60mg)
This is a description of a medication called Lurasidone Hydrochloride Tablets. Each film-coated tablet contains 60mg of Lurasidone Hydrochloride, with a usual dose indicated in the package insert. It is to be stored at 20°C to 25°C. The tablets are manufactured by Dr. Reddy's Laboratories Limited in India and sold by Torrent Pharma Inc in NJ, USA. The accompanying medication guide must be given to the patient every time this medication is dispensed. No additional information is available.*
Image Description (Figure1)
This text describes the impact of other drugs on Lurasidone Pharmacokinetics(PK). It provides information about the Cmax and AuC for different interacting drugs like strong CYP3A4 inhibitors such as Ketoconazole, moderate CYP3A4 inhibitors like Diltazem and strong CYP3A4 inducers like Rifampin. It also gives values for Lithium. The last line mentions the relative change in comparison to Lurasidone taken alone.*
Image Description (Figure2)
Image Description (Figure3)
Image Description (Logo Pi)
Image Description (Logo mg)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
